Data / Research funding / Tennessee / ST. Jude Children's Research Hospital
ST. Jude Children's Research Hospital: 282 NIH awards ($571.1M) and 4 NSF awards ($1.6M), fiscal years 2021 to 2026
ST. Jude Children's Research Hospital in Memphis, TN is funded under 282 NIH awards ($571.1M) and 4 NSF awards ($1.6M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- JL4JHE9SDRR3
- State
- Tennessee
Awards
286 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: AVIAN INFLUENZA RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $91,354,067 | April 1, 2021 | January 14, 2027 | WEBBY, RICHARD | reporter.nih.gov |
| Cancer Center Support Grant (CCSG) | NIH | National Cancer Institute | 2021 to 2025 | $35,080,297 | April 1, 1997 | February 28, 2026 | ROBERTS, CHARLES | reporter.nih.gov |
| DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $30,010,720 | May 2, 2019 | April 30, 2027 | WEBBY, RICHARD JOHN | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| NORMAL & NEOPLASTIC GROWTH IN THE BRAIN | NIH | National Cancer Institute | 2021 to 2025 | $9,213,777 | April 1, 2003 | August 31, 2026 | BAKER, SUZANNE J. | reporter.nih.gov |
| Translating genomic discoveries to improved outcomes for high risk acute leukemia | NIH | National Cancer Institute | 2021 to 2025 | $6,239,168 | January 19, 2017 | August 31, 2030 | MULLIGHAN, CHARLES G | reporter.nih.gov |
| Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $5,451,449 | September 1, 1997 | June 30, 2024 | WEISS, MITCHELL J | reporter.nih.gov |
| Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,241,422 | July 21, 2020 | June 30, 2027 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| MECHANISMS OF REGULATED CELL DEATH | NIH | National Cancer Institute | 2021 to 2025 | $5,239,428 | September 1, 2018 | August 31, 2029 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Early life respiratory viral infections shape immune development trajectories | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,142,918 | April 1, 2022 | March 31, 2027 | RAMILO, OCTAVIO | reporter.nih.gov |
| Identifying the mechanisms of leukemia progression | NIH | National Cancer Institute | 2021 to 2025 | $5,032,279 | September 22, 2021 | August 31, 2028 | CRISPINO, JOHN D | reporter.nih.gov |
| Integrating systems immunology with immunometabolism and cancer immunity | NIH | National Cancer Institute | 2021 to 2025 | $4,934,381 | August 1, 2021 | July 31, 2028 | CHI, HONGBO | reporter.nih.gov |
| The St. Jude Lifetime Cohort | NIH | National Cancer Institute | 2021 to 2024 | $4,907,509 | July 9, 2015 | June 30, 2025 | HUDSON, MELISSA M | reporter.nih.gov |
| Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,212,442 | June 15, 2021 | May 31, 2026 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Base editing and prime editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,000,055 | January 1, 2021 | June 30, 2030 | WEISS, MITCHELL J | reporter.nih.gov |
| Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,710,340 | September 1, 2023 | August 31, 2028 | WEISS, MITCHELL J | reporter.nih.gov |
| Mapping the genomic and molecular mechanisms of antifungal resistance in the emerging fungal pathogen Candida auris | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,661,637 | March 6, 2023 | February 29, 2028 | ROGERS, P. DAVID | reporter.nih.gov |
| In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas | NIH | National Cancer Institute | 2021 to 2025 | $3,632,740 | July 1, 2021 | June 30, 2027 | DYER, MICHAEL A | reporter.nih.gov |
| Dynamic RNA-protein assemblies and neurological disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,563,075 | December 1, 2016 | April 30, 2025 | TAYLOR, JOSEPH PAUL | reporter.nih.gov |
| Epigenetic Checkpoint Regulation of Naive T-cell Quiescence and Peripheral Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,428,212 | July 22, 2025 | June 30, 2029 | FENG, YONGQIANG | reporter.nih.gov |
| Cortical Mechanisms of Innate Frequency Discrimination | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $3,262,585 | August 6, 2025 | July 31, 2029 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Spectinomycin analogs for NTM infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,229,019 | September 17, 2020 | August 31, 2025 | LEE, RICHARD E. | reporter.nih.gov |
| DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHC | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,185,903 | June 20, 2018 | September 21, 2025 | THOMAS, PAUL G. | reporter.nih.gov |
| Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma | NIH | National Cancer Institute | 2025 | $3,128,074 | September 20, 2022 | May 31, 2028 | BRINKMAN, TARA M | reporter.nih.gov |
| Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,121,003 | February 1, 2021 | January 31, 2027 | MITTAG, TANJA | reporter.nih.gov |
| Structure and functional mechanisms of molecular chaperones and protein kinases | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,046,637 | May 1, 2017 | January 31, 2028 | KALODIMOS, CHARALAMPOS | reporter.nih.gov |
| Fusion oncoprotein condensates in pediatric cancers | NIH | National Cancer Institute | 2025 | $3,032,826 | September 1, 2025 | August 31, 2030 | KRIWACKI, RICHARD W | reporter.nih.gov |
| Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia | NIH | National Cancer Institute | 2021 to 2025 | $2,961,810 | July 1, 2021 | June 30, 2026 | YANG, JUN J. | reporter.nih.gov |
| Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors | NIH | National Cancer Institute | 2022 to 2025 | $2,924,883 | March 1, 2022 | February 28, 2027 | DERENZO, CHRISTOPHER | reporter.nih.gov |
| Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $2,900,455 | July 5, 2021 | June 30, 2027 | HUANG, I-CHAN | reporter.nih.gov |
| Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,872,000 | April 2, 2021 | January 31, 2027 | YANG, JUN J. | reporter.nih.gov |
| Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $2,776,588 | September 16, 2021 | August 31, 2026 | YU, JIYANG | reporter.nih.gov |
| Understanding Metabolism in Space and Time – Mechanistic Analysis of the Dynamic Spatial Organization of Metabolism | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,748,000 | September 1, 2022 | August 31, 2027 | CHANG, CHI-LUN | reporter.nih.gov |
| EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA | NIH | National Cancer Institute | 2022 to 2025 | $2,717,300 | July 1, 2022 | June 30, 2027 | YANG, JUN | reporter.nih.gov |
| Innate immune signaling and stress response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,692,500 | March 15, 2016 | February 28, 2026 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Sustainability determinants of an intervention to identify clinical deterioration and improve childhood cancer survival in low-resource hospitals | NIH | National Cancer Institute | 2023 to 2025 | $2,669,584 | April 1, 2023 | March 31, 2028 | AGULNIK, ASYA | reporter.nih.gov |
| eHealth Intervention for Late Effects of Childhood Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,636,602 | September 1, 2019 | February 28, 2026 | BRINKMAN, TARA M | reporter.nih.gov |
| ULK-mediated autophagy of α-globin in ß-thalassemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,597,287 | July 1, 2022 | June 30, 2027 | WEISS, MITCHELL J | reporter.nih.gov |
| Targeting NuoD for the treatment of H. pylori | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,555,440 | May 1, 2023 | April 30, 2028 | LEE, RICHARD E. | reporter.nih.gov |
| Hybrid Antibiotics for Persistent Infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,536,284 | September 26, 2023 | July 31, 2028 | LEE, RICHARD E. | reporter.nih.gov |
| Developing and Discovering Covalent Inhibitors through Fragmentation-First Experimentation | NIH | National Institute of General Medical Sciences | 2025 | $2,503,299 | September 1, 2025 | August 31, 2029 | BLAIR, DANIEL JAMES | reporter.nih.gov |
| Role of Phase separation by fusion oncoproteins in oncogenesis | NIH | National Cancer Institute | 2021 to 2024 | $2,490,785 | December 6, 2019 | November 30, 2024 | KRIWACKI, RICHARD W | reporter.nih.gov |
| Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequences | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,434,773 | July 1, 2022 | June 30, 2027 | ROSCH, JASON W. | reporter.nih.gov |
| Effects of obesity on the dynamics of Influenza transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,430,473 | June 10, 2019 | May 31, 2025 | SCHULTZ-CHERRY, STACEY L | reporter.nih.gov |
| Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology | NIH | National Cancer Institute | 2023 to 2025 | $2,416,050 | September 7, 2023 | August 31, 2028 | CHI, HONGBO | reporter.nih.gov |
| Deciphering the complexities of inflammasome activation following RSV infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,386,192 | July 1, 2022 | June 30, 2027 | VARGA, STEVEN M | reporter.nih.gov |
| Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations | NIH | National Cancer Institute | 2021 to 2025 | $2,360,075 | March 17, 2021 | May 31, 2026 | GEELEHER, PAUL | reporter.nih.gov |
| Improving predictive capacity of models for universal influenza vaccine development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,303,623 | August 1, 2020 | July 31, 2025 | WEBBY, RICHARD JOHN | reporter.nih.gov |
| Inflammatory Caspases in Innate Immunity and Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,268,750 | May 1, 2012 | April 30, 2027 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,268,750 | May 1, 2022 | April 30, 2027 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Metabolic checkpoint in dendritic cell subsets and adaptive immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,256,250 | February 1, 2024 | December 31, 2028 | CHI, HONGBO | reporter.nih.gov |
| Bioactivities of pneumococcal cell wall in neuropathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,255,100 | November 4, 2016 | January 31, 2027 | TUOMANEN, ELAINE I | reporter.nih.gov |
| Exploiting Water Network Perturbations in Protein Binding Sites | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,243,245 | August 1, 2021 | May 31, 2027 | FISCHER, MARCUS | reporter.nih.gov |
| Robust immune tolerance conferred by Foxp3 transcriptional regulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,230,288 | January 20, 2021 | December 31, 2025 | FENG, YONGQIANG | reporter.nih.gov |
| Interneuron circuits in the spinal motor system | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,229,745 | May 15, 2021 | April 30, 2027 | BIKOFF, JAY BENJAMIN | reporter.nih.gov |
| Improving genetically engineered T cells for medulloblastomas | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,210,532 | April 15, 2021 | April 30, 2026 | KRENCIUTE, GIEDRE | reporter.nih.gov |
| Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,175,216 | April 1, 2016 | May 31, 2026 | CHEN, TAOSHENG | reporter.nih.gov |
| Patient-Reported Outcomes Version of CTCAE involving Childhood Cancer Survivors | NIH | National Cancer Institute | 2021 to 2023 | $2,133,713 | August 15, 2019 | July 31, 2025 | HUANG, I-CHAN | reporter.nih.gov |
| Mechanisms of Sonic Hedgehog Signal Transduction | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,117,185 | August 1, 2017 | July 31, 2028 | OGDEN, STACEY KATHRYN | reporter.nih.gov |
| Investigating hematopoietic stem cell dysfunction during sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,111,564 | April 1, 2023 | March 31, 2027 | MCKINNEY-FREEMAN, SHANNON L | reporter.nih.gov |
| The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | NIH | National Cancer Institute | 2021 to 2025 | $2,106,784 | July 1, 2005 | March 31, 2026 | ROBERTS, CHARLES | reporter.nih.gov |
| Mapping the Cerebellar Origins of Medulloblastoma Subgroups | NIH | National Cancer Institute | 2023 to 2025 | $2,099,734 | February 16, 2023 | January 31, 2028 | NORTHCOTT, PAUL | reporter.nih.gov |
| EPIGENETIC REPROGRAMMING OF T CELL EXHAUSTION TO ENHANCE TUMOR IMMUNOTHERAPY | NIH | National Cancer Institute | 2021 to 2025 | $2,070,977 | March 1, 2020 | March 31, 2030 | YOUNGBLOOD, BENJAMIN ALAN | reporter.nih.gov |
| Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma | NIH | National Cancer Institute | 2023 to 2025 | $2,052,826 | September 7, 2023 | August 31, 2028 | MACK, STEPHEN C | reporter.nih.gov |
| Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma | NIH | National Cancer Institute | 2021 to 2025 | $2,016,077 | February 1, 2021 | January 31, 2027 | HATLEY, MARK EDWARD | reporter.nih.gov |
| Consequences of Direct Viral-Bacterial Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,014,549 | January 5, 2022 | December 31, 2026 | ROSCH, JASON W. | reporter.nih.gov |
| GENETICALLY ENGINEERED T CELLS FOR DIPG | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,999,395 | August 1, 2022 | July 31, 2027 | KRENCIUTE, GIEDRE | reporter.nih.gov |
| Transporters and Medulloblastoma | NIH | National Cancer Institute | 2021 to 2025 | $1,995,922 | April 1, 2015 | November 30, 2026 | SCHUETZ, JOHN D | reporter.nih.gov |
| Transcriptional and metabolic heterogeneity in T cell differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,989,500 | July 1, 2018 | April 30, 2029 | CHI, HONGBO | reporter.nih.gov |
| Novel Therapeutic Approaches for the Treatment of Neuroblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,988,123 | April 1, 2020 | March 31, 2026 | DYER, MICHAEL A | reporter.nih.gov |
| Regulation of collagen linearization during cancer progression and metastasis | NIH | National Cancer Institute | 2021 to 2025 | $1,984,680 | July 20, 2020 | February 28, 2027 | LABELLE, MYRIAM | reporter.nih.gov |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,915,725 | September 20, 2018 | June 30, 2023 | CAUDLE, KELLY E. | reporter.nih.gov |
| Transcriptional Regulation in ZFTA-RELA Ependymoma | NIH | National Cancer Institute | 2023 to 2025 | $1,877,375 | August 1, 2023 | July 31, 2028 | MACK, STEPHEN C | reporter.nih.gov |
| Measuring Lifelong Multimorbidity with Patient Perspectives: Implementing and Visualizing the Cumulative Burden Methodology Across Cohorts | NIH | National Cancer Institute | 2022 to 2025 | $1,843,355 | March 11, 2022 | February 28, 2026 | BHAKTA, NICKHILL HITESH | reporter.nih.gov |
| Structural and Functional Studies of Human Serine Palmitoyltransferase Complexes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,839,875 | August 1, 2021 | April 30, 2026 | LEE, CHIA-HSUEH | reporter.nih.gov |
| Antibiotic tolerance: membraneless organelles and autolysin regulation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,820,000 | May 5, 2022 | April 30, 2027 | TUOMANEN, ELAINE I | reporter.nih.gov |
| Genome Stability in Glia & Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,806,350 | July 1, 2022 | June 30, 2027 | MCKINNON, PETER J | reporter.nih.gov |
| Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,795,000 | April 1, 2021 | February 28, 2026 | SUN, JI | reporter.nih.gov |
| Understanding the developmental progression of subpallial neural progenitor cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,781,538 | August 1, 2021 | June 30, 2025 | CAO, XINWEI | reporter.nih.gov |
| Dissecting the role of NEU1-dependent de-sialylation in neurodegeneration and neuroinflammation | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,750,578 | July 15, 2021 | December 31, 2024 | D'AZZO, ALESSANDRA | reporter.nih.gov |
| Computational tools for estimating cell-type-specific effects in bulk RNA-seq and spatial transcriptomics data, using reference single-cell RNA-seq datasets | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,747,000 | August 1, 2020 | May 31, 2026 | GEELEHER, PAUL | reporter.nih.gov |
| PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | NIH | National Cancer Institute | 2022 to 2025 | $1,728,000 | July 1, 1978 | April 30, 2027 | GRONEMEYER, SUZANNE A. | reporter.nih.gov |
| Role of the SWI/SNF complex in tumor suppression | NIH | National Cancer Institute | 2021 to 2025 | $1,690,815 | July 1, 2013 | January 31, 2029 | ROBERTS, CHARLES | reporter.nih.gov |
| Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2022 to 2025 | $1,672,253 | August 1, 2022 | July 31, 2027 | MA, XIAOTU | reporter.nih.gov |
| Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,653,519 | December 1, 2020 | November 30, 2026 | MACK, STEPHEN C | reporter.nih.gov |
| XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION | NIH | National Cancer Institute | 2022 to 2025 | $1,636,159 | March 3, 2022 | February 28, 2027 | ZAMBETTI, GERARD PAUL | reporter.nih.gov |
| The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma | NIH | National Cancer Institute | 2022 to 2025 | $1,636,159 | March 4, 2022 | February 28, 2027 | CHEN, XIANG | reporter.nih.gov |
| Understanding Phase Separation in Biology and Disease | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,615,500 | July 1, 2019 | April 30, 2024 | KRIWACKI, RICHARD W | reporter.nih.gov |
| Bidirectional metabolic signaling in follicular helper T cell differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,608,834 | September 19, 2019 | August 31, 2025 | CHI, HONGBO | reporter.nih.gov |
| Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids | NIH | National Cancer Institute | 2021 to 2024 | $1,605,471 | May 15, 2020 | April 30, 2026 | DYER, MICHAEL A | reporter.nih.gov |
| Developing and validating race-specific cardiomyopathy risk prediction models in African American survivors of childhood cancer | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,586,554 | May 15, 2024 | April 30, 2028 | SAPKOTA, YADAV | reporter.nih.gov |
| Sonic Hedgehog Signaling in Neocortical Growth and Folding | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,554,342 | September 30, 2017 | December 31, 2028 | HAN, YOUNG-GOO | reporter.nih.gov |
| Investigating the mechanisms of lysosome segregation and cell fate regulation in dividing hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,546,514 | September 1, 2024 | August 31, 2029 | LOEFFLER, DIRK | reporter.nih.gov |
| Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,526,635 | July 6, 2010 | February 29, 2024 | LEE, RICHARD E. | reporter.nih.gov |
| Trajectory of epigenetic aging and health outcomes in childhood cancer survivors | NIH | National Cancer Institute | 2024 to 2025 | $1,509,154 | May 1, 2024 | April 30, 2026 | NESS, KIRSTEN KIMBERLIE | reporter.nih.gov |
| Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcome | NIH | National Cancer Institute | 2021 to 2023 | $1,456,346 | August 1, 2019 | July 31, 2025 | SAVIC, DANIEL | reporter.nih.gov |
| Regulation of lipid metabolism in bacteria | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,446,048 | December 1, 1984 | November 30, 2023 | ROCK, CHARLES O | reporter.nih.gov |
| Molecular Analysis of Transcriptional Enhancers in Hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,444,363 | September 19, 2016 | March 31, 2026 | XU, JIAN | reporter.nih.gov |
| Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,437,300 | June 1, 2023 | May 31, 2027 | TSAI, SHENGDAR | reporter.nih.gov |
| Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,437,300 | May 17, 2023 | April 30, 2027 | TSAI, SHENGDAR | reporter.nih.gov |
| Chromatin of repetitive elements | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,436,000 | April 1, 2021 | March 31, 2026 | HALIC, MARIO | reporter.nih.gov |
| Regulation of T cell memory in tissue immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,435,852 | February 13, 2018 | October 31, 2029 | CHI, HONGBO | reporter.nih.gov |
| Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia | NIH | National Cancer Institute | 2023 to 2025 | $1,425,147 | December 1, 2021 | November 30, 2026 | XU, JIAN | reporter.nih.gov |
| Genetic pleiotropy across pediatric cancers, and cancer-related outcomes | NIH | National Cancer Institute | 2024 to 2025 | $1,395,864 | May 16, 2024 | April 30, 2029 | WANG, ZHAOMING | reporter.nih.gov |
| Gene regulation for stem cell differentiation | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,392,584 | September 1, 2019 | May 31, 2025 | PENG, JAMY C. | reporter.nih.gov |
| Imaging Protein Synthesis on the Ribosome using Single-Molecule FRET | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,386,639 | September 15, 2006 | July 31, 2025 | BLANCHARD, SCOTT C | reporter.nih.gov |
| Telehealth based exercise intervention to improve functional capacity in survivors of childhood cancer with significantly limited exercise tolerance | NIH | National Cancer Institute | 2023 to 2024 | $1,377,707 | September 16, 2020 | August 31, 2025 | NESS, KIRSTEN KIMBERLIE | reporter.nih.gov |
| Training in Pediatric Cancer Survivorship Outcomes and Interventions | NIH | National Cancer Institute | 2021 to 2025 | $1,373,617 | April 1, 2018 | August 31, 2028 | KRULL, KEVIN R | reporter.nih.gov |
| Genomics-based Mechanistic Investigation of Cancer-treatment Related Cardiotoxicity among Survivors of Childhood Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,373,343 | May 3, 2024 | April 30, 2026 | SAPKOTA, YADAV | reporter.nih.gov |
| Structural analysis of the human LRRK2 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,351,350 | May 17, 2023 | April 30, 2028 | LEE, CHIA-HSUEH | reporter.nih.gov |
| Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,346,250 | January 1, 2019 | December 31, 2024 | KLCO, JEFFERY M | reporter.nih.gov |
| Structural insight into novel mechanisms of type III secretion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,346,250 | December 1, 2011 | April 30, 2025 | KALODIMOS, CHARALAMPOS | reporter.nih.gov |
| Non-canonical functions of autophagy proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,346,250 | May 1, 1997 | May 31, 2024 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,346,250 | September 19, 2014 | August 31, 2025 | CHI, HONGBO | reporter.nih.gov |
| Identification of causal non-coding variants in childhood genetic disorders | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,346,250 | September 1, 2019 | August 31, 2025 | CHENG, YONG | reporter.nih.gov |
| Clinical trial of AAV8-mediated FVIII gene transfer for hemophilia A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,338,564 | January 10, 2018 | November 30, 2023 | DAVIDOFF, ANDREW M | reporter.nih.gov |
| Cell-type– and developmental stage–specific regulation of gene expression in the retina | NIH | National Eye Institute | 2021 to 2023 | $1,319,324 | February 1, 2020 | January 31, 2025 | DYER, MICHAEL A | reporter.nih.gov |
| Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma | NIH | National Cancer Institute | 2022 | $1,293,841 | September 20, 2022 | December 31, 2024 | BRINKMAN, TARA M | reporter.nih.gov |
| Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,282,528 | August 1, 2021 | July 31, 2027 | GUTIERREZ, ALEJANDRO | reporter.nih.gov |
| Neurostimulation in Adult Survivors of Childhood Leukemia | NIH | National Cancer Institute | 2021 to 2022 | $1,282,490 | May 1, 2019 | April 30, 2025 | BRINKMAN, TARA M | reporter.nih.gov |
| Mechanistic Studies Of The Staphylococcus aureus LukAB Cytotoxin | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,274,906 | June 4, 2013 | October 31, 2028 | TORRES, VICTOR J. | reporter.nih.gov |
| Childhood Hematological Malignancies Training Program | NIH | National Cancer Institute | 2021 to 2025 | $1,268,552 | August 8, 2019 | July 31, 2029 | MULLIGHAN, CHARLES G | reporter.nih.gov |
| Cancer-based discovery of novel mechanisms of chromatin control | NIH | National Cancer Institute | 2023 to 2025 | $1,228,160 | April 6, 2023 | March 31, 2028 | ROBERTS, CHARLES | reporter.nih.gov |
| UBTF Tandem Duplications in Pediatric Acute Myeloid Leukemia | NIH | National Cancer Institute | 2023 to 2025 | $1,228,160 | September 22, 2023 | August 31, 2028 | KLCO, JEFFERY M | reporter.nih.gov |
| A novel human T-cell platform to define biological effects of genome editing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,220,029 | September 12, 2018 | June 30, 2024 | TSAI, SHENGDAR | reporter.nih.gov |
| Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,217,050 | July 1, 2018 | April 30, 2024 | ANSARI, ASEEM Z | reporter.nih.gov |
| Bromodomain-selective inhibitors for cancer therapy | NIH | National Cancer Institute | 2021 to 2023 | $1,215,394 | September 5, 2019 | August 31, 2025 | SHELAT, ANANG A | reporter.nih.gov |
| CEIRS - SARS-CoV-2 RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,209,203 | April 1, 2014 | May 20, 2022 | WEBBY, RICHARD | reporter.nih.gov |
| Dissecting high-risk cell states in neuroblastoma | NIH | National Cancer Institute | 2024 to 2025 | $1,205,608 | March 1, 2024 | February 28, 2029 | DURBIN, ADAM DAVID | reporter.nih.gov |
| Discovering the mechanisms underlying oncogenesis by ZFTA-RELA and pinpointing therapeutic targets. | NIH | National Cancer Institute | 2024 to 2025 | $1,202,500 | September 13, 2024 | August 31, 2029 | MACK, STEPHEN C | reporter.nih.gov |
| The Role of Modular Super-Enhancers in the Developing Murine and Human Retina | NIH | National Eye Institute | 2024 to 2025 | $1,193,028 | August 1, 2024 | March 31, 2029 | DYER, MICHAEL A | reporter.nih.gov |
| WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor | NIH | National Cancer Institute | 2021 to 2025 | $1,184,821 | January 1, 2021 | December 31, 2026 | MURPHY, ANDREW J | reporter.nih.gov |
| Deconstructing pineoblastoma origins to advance disease biology, modeling, and therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,176,667 | June 15, 2024 | May 31, 2029 | NORTHCOTT, PAUL | reporter.nih.gov |
| Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis | NIH | National Institute on Aging | 2024 | $1,171,075 | September 15, 2020 | August 31, 2025 | PENG, JUNMIN | reporter.nih.gov |
| ClinGen Expert Curation Panel for the Epilepsies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,168,722 | August 1, 2021 | July 31, 2025 | MEFFORD, HEATHER C. | reporter.nih.gov |
| Structural and functional studies of chromatin modifiers | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,130,850 | January 1, 2020 | December 31, 2024 | HALIC, MARIO | reporter.nih.gov |
| Sensory-evoked adenosine release in cortical plasticity | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,123,568 | August 1, 2024 | May 31, 2029 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers | NIH | National Cancer Institute | 2021 to 2022 | $1,116,947 | June 1, 2018 | May 31, 2023 | ZHANG, JINGHUI | reporter.nih.gov |
| Training in the Design and Development of Infectious Disease Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,087,433 | July 8, 2015 | October 31, 2026 | LEE, RICHARD E. | reporter.nih.gov |
| The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,077,000 | January 1, 2015 | December 31, 2024 | MITTAG, TANJA | reporter.nih.gov |
| The St. Jude Lifetime Cohort Study | NIH | National Cancer Institute | 2025 | $1,059,908 | August 1, 2025 | July 31, 2030 | HUDSON, MELISSA M | reporter.nih.gov |
| Structural and functional investigations on synaptic vesicular transporters | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,046,774 | March 1, 2024 | February 28, 2029 | LEE, CHIA-HSUEH | reporter.nih.gov |
| Dissecting the contributions of phase separation to yeast transcription . | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,031,008 | September 1, 2024 | July 31, 2028 | MITTAG, TANJA | reporter.nih.gov |
| Intracellular and Intercellular Network Rewiring and Hidden Driver Inference from Single-Cell Data | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,019,562 | September 9, 2019 | August 31, 2024 | YU, JIYANG | reporter.nih.gov |
| Targeting EP300, a selective dependency in neuroblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,011,846 | September 14, 2020 | August 31, 2025 | DURBIN, ADAM DAVID | reporter.nih.gov |
| Mechanistic Basis of Calcium Sensing Receptor Signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $997,212 | April 1, 2022 | March 31, 2027 | SKINIOTIS, GEORGIOS | reporter.nih.gov |
| The role of the N-terminus of GATA1 in erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $950,040 | August 11, 2024 | July 31, 2028 | CRISPINO, JOHN D | reporter.nih.gov |
| Towards understanding cellular mechanisms of positive symptoms of schizophrenia | NIH | National Institute of Mental Health | 2021 to 2022 | $940,196 | July 1, 2013 | March 31, 2024 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Chemical approaches for targeting ribonucleoprotein assemblies | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $925,000 | September 10, 2024 | July 31, 2029 | CUPIDO, TOMMASO | reporter.nih.gov |
| Structural Basis of Signal Instigation Through Family C GPCRs | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $923,391 | March 15, 2021 | February 28, 2027 | SKINIOTIS, GEORGIOS | reporter.nih.gov |
| Synaptic mechanisms of auditory memory | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $920,978 | July 1, 2013 | August 31, 2023 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | NIH | National Institute on Aging | 2024 to 2025 | $915,125 | June 1, 2024 | February 28, 2029 | DEMONTIS, FABIO | reporter.nih.gov |
| Proteogenomics of Splicing Proteinopathies in Neurodegeneration | NIH | National Institute on Aging | 2025 | $913,225 | June 1, 2025 | March 31, 2030 | PENG, JUNMIN | reporter.nih.gov |
| Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $899,780 | April 1, 2020 | March 31, 2025 | KAROL, SETH EVAN | reporter.nih.gov |
| Role of the autophagy-inducing kinases ULK1/2 in ER export and protein trafficking | NIH | National Institute of Mental Health | 2021 to 2022 | $897,500 | August 1, 2018 | April 30, 2024 | KUNDU, MONDIRA | reporter.nih.gov |
| Dynamic RNA-Protein Assemblies and Neurological Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $897,250 | May 1, 2025 | April 30, 2033 | TAYLOR, JOSEPH PAUL | reporter.nih.gov |
| [18F]fluoromannitol: A novel imaging agent to delineate osteomyelitis in sickle cell disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $894,735 | February 26, 2025 | January 31, 2029 | NEUMANN, KIEL | reporter.nih.gov |
| Pathogenesis of ETV6-Related Acute Lymphoblastic Leukemia | NIH | National Cancer Institute | 2023 to 2025 | $849,360 | April 1, 2020 | March 31, 2027 | NICHOLS, KIM ERIKA | reporter.nih.gov |
| T32 Training Program in Pediatric Immuno-Oncology and Immunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $830,706 | September 1, 2022 | August 31, 2027 | GOTTSCHALK, STEPHEN | reporter.nih.gov |
| Dissecting the Spectrum, Prevalence, and Molecular Mechanisms of Enhancer Hijacking in Medulloblastoma | NIH | National Cancer Institute | 2021 to 2022 | $821,212 | September 21, 2018 | August 31, 2024 | NORTHCOTT, PAUL | reporter.nih.gov |
| Deciphering the underlying structure of the glucocorticoid gene regulatory network | NIH | National Human Genome Research Institute | 2025 | $814,368 | April 1, 2025 | March 31, 2029 | SAVIC, DANIEL | reporter.nih.gov |
| Improving HSC transplantation by defining novel regulators of engraftment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $807,750 | February 1, 2019 | December 31, 2023 | MCKINNEY-FREEMAN, SHANNON L | reporter.nih.gov |
| ATM and DNA Damage in the Nervous System | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $785,312 | August 1, 1998 | January 31, 2024 | MCKINNON, PETER J | reporter.nih.gov |
| Siah2: an E3 ligase organizes polarity and cytoskeletal links in neuron migration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $785,312 | July 1, 2018 | June 30, 2024 | SOLECKI, DAVID JOSEPH | reporter.nih.gov |
| Memphis STEM-M Ambassadors | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $774,048 | September 5, 2023 | August 31, 2028 | AYERS, KATHERINE | reporter.nih.gov |
| Role of IL-1alpha signaling in inflammatory diseases and host defense | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $774,004 | September 15, 2008 | July 31, 2023 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| Evaluation of Cardiovascular Health Outcomes among Survivors 2 (ECHOS-2) | NIH | National Cancer Institute | 2025 | $772,418 | September 1, 2025 | August 31, 2030 | EHRHARDT, MATTHEW JAMES | reporter.nih.gov |
| Targeting EP300 epigenomic control in neuroblastoma | NIH | National Cancer Institute | 2025 | $768,713 | August 1, 2025 | July 31, 2030 | DURBIN, ADAM DAVID | reporter.nih.gov |
| Targeting splicing vulnerability of neuroblastoma | NIH | National Cancer Institute | 2025 | $767,328 | August 1, 2025 | July 31, 2030 | YANG, JUN | reporter.nih.gov |
| Structural Basis of Programmable DNA-Insertion via Cryo-EM Studies of CRISPR-Associated TnsC | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $764,400 | January 1, 2022 | December 31, 2026 | KELLOGG, ELIZABETH | reporter.nih.gov |
| IMPROVING PROGNOSTIC COMMUNICATION IN PEDIATRIC CANCER | NIH | National Cancer Institute | 2022 to 2025 | $756,252 | August 1, 2022 | November 30, 2027 | KAYE, ERICA CARMEN | reporter.nih.gov |
| Mechanisms of Mitochondrial Degradation in Unstressed Mammalian Cells | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $753,900 | March 10, 2020 | February 29, 2024 | KUNDU, MONDIRA | reporter.nih.gov |
| Extracellular matrix in vertebrate hematopoietic stem cell specification | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $740,000 | August 15, 2024 | May 31, 2027 | CLEMENTS, WILSON KENDRICK | reporter.nih.gov |
| Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | NIH | National Cancer Institute | 2025 | $738,024 | January 1, 2025 | December 31, 2029 | FISCHER, MARCUS | reporter.nih.gov |
| Thalamocortical disruption as a convergence point for schizophrenia risks | NIH | National Institute of Mental Health | 2025 | $735,932 | April 3, 2025 | January 31, 2030 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Advancing Pantothenate Kinase Activation Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $735,373 | September 1, 2025 | May 31, 2030 | LEE, RICHARD E. | reporter.nih.gov |
| Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | NIH | National Institute of Mental Health | 2025 | $731,035 | June 1, 2025 | March 31, 2030 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | NIH | National Cancer Institute | 2025 | $718,113 | January 15, 2025 | December 31, 2029 | YANG, JUN | reporter.nih.gov |
| Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $676,388 | January 1, 2025 | December 31, 2029 | SOLECKI, DAVID JOSEPH | reporter.nih.gov |
| Structural and Functional Studies of Chromatin | NIH | National Institute of General Medical Sciences | 2025 | $667,480 | May 1, 2025 | April 30, 2030 | HALIC, MARIO | reporter.nih.gov |
| RE-aiming at Hydroxyurea Adherence for Sickle cell with mHealth (RE-HASH) | NIH | National Heart, Lung, and Blood Institute | 2021 | $638,420 | August 8, 2016 | June 30, 2023 | HANKINS, JANE SILVA | reporter.nih.gov |
| Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing | NIH | National Cancer Institute | 2021 | $628,281 | April 18, 2017 | March 31, 2024 | YASUI, YUTAKA | reporter.nih.gov |
| The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | NIH | National Eye Institute | 2025 | $606,034 | February 1, 2025 | January 31, 2030 | DYER, MICHAEL A | reporter.nih.gov |
| Reprogram long-lived effector T cells for cancer immunotherapy | NIH | National Cancer Institute | 2021 | $594,393 | March 6, 2020 | February 28, 2022 | CHI, HONGBO | reporter.nih.gov |
| Improving CAR T-cell therapy for Pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL) | NIH | National Cancer Institute | 2024 to 2025 | $578,916 | September 1, 2024 | August 31, 2029 | TALLEUR, AIMEE C. | reporter.nih.gov |
| Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA | NIH | National Cancer Institute | 2021 | $565,224 | August 1, 2017 | July 31, 2023 | KRULL, KEVIN R | reporter.nih.gov |
| Collaborative Research: Promoting Meaningful Collaboration in a STEM + Medicine Learning Ecosystem | NSF | Division of Research on Learning in Formal and Informal Settings (DRL) | 2024 | $559,342 | September 15, 2024 | April 25, 2025 | Katherine Ayers | nsf.gov |
| Contribution of LukED to Staphylococcus aureus pathobiology | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $556,035 | December 1, 2013 | June 30, 2025 | TORRES, VICTOR J. | reporter.nih.gov |
| Consequences of Direct Viral-Bacterial Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $531,058 | July 20, 2021 | June 30, 2023 | ROSCH, JASON W. | reporter.nih.gov |
| Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth” | NIH | National Cancer Institute | 2023 to 2025 | $527,556 | August 1, 2023 | November 30, 2028 | ZEBLEY, CAITLIN | reporter.nih.gov |
| Dissecting neomorphic functions mediated by mutant-specific structures of SPOP | NIH | National Cancer Institute | 2025 | $524,560 | May 21, 2025 | April 30, 2030 | MITTAG, TANJA | reporter.nih.gov |
| Upc2A: A Central Regulator and "Achilles' Heel" of Fluconazole Resistance in Candida glabrata | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $512,508 | February 7, 2017 | January 31, 2023 | ROGERS, P. DAVID | reporter.nih.gov |
| Epigenetic gene regulation for stem cell fates | NIH | National Institute of General Medical Sciences | 2025 | $508,750 | June 5, 2025 | March 31, 2030 | PENG, JAMY C. | reporter.nih.gov |
| Elucidating chromatin structure and function of double minutes through cell cycles | NIH | National Institute of General Medical Sciences | 2025 | $508,750 | August 1, 2025 | May 31, 2030 | DAO, HAI | reporter.nih.gov |
| Bacterial Community Barrier to Vancomycin Resistant Enterococcus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $508,375 | June 4, 2024 | May 31, 2026 | MARGOLIS, ELISA B H | reporter.nih.gov |
| Mapping tauopathy-induced changes in subcellular proteostasis with compartment-targeted sensors | NIH | National Institute on Aging | 2022 | $500,500 | July 15, 2022 | June 30, 2025 | DEMONTIS, FABIO | reporter.nih.gov |
| Determination of chromatin protein dynamics in CD8 T cells | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $500,500 | June 23, 2023 | March 31, 2026 | FENG, YONGQIANG | reporter.nih.gov |
| Targeting the immunoproteasome as a novel therapeutic strategy for hemophagocytic lymphohistiocytosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $500,500 | July 5, 2023 | June 30, 2026 | NICHOLS, KIM ERIKA | reporter.nih.gov |
| LRRC57 modulates neurotrophic growth factor signaling in synaptic function and behavior | NIH | National Institute of Mental Health | 2024 | $500,500 | August 1, 2024 | July 31, 2026 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Structural and Pharmacological Study of the KCNQ1/KCNE1 Potassium Channel Complex | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $498,000 | July 12, 2018 | December 31, 2023 | SUN, JI | reporter.nih.gov |
| Cis-interaction mediated CD28 costimulation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $498,000 | August 5, 2022 | December 31, 2026 | ZHAO, YUNLONG | reporter.nih.gov |
| Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $493,675 | February 1, 2024 | December 31, 2026 | ROSCH, JASON W. | reporter.nih.gov |
| Characterization of TCS11 in Streptococcus pneumoniae | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $493,675 | February 1, 2024 | December 31, 2026 | ROSCH, JASON W. | reporter.nih.gov |
| Identify novel modulators of regulatory T cell function from the dynamic cis-proteomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $493,625 | June 11, 2021 | November 30, 2023 | FENG, YONGQIANG | reporter.nih.gov |
| School Readiness Intervention for Preschool Children with Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $484,248 | May 10, 2023 | April 30, 2028 | HEITZER, ANDREW M | reporter.nih.gov |
| Novel Azole Resistance Mechanisms in Candida albicans | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $476,540 | June 1, 2005 | May 31, 2023 | ROGERS, P. DAVID | reporter.nih.gov |
| Caregiver Education with Interactive Neurodevelopmental Games to Improve Cognitive and Social-Emotional Outcomes in Infants Undergoing Treatment for Medulloblastoma | NIH | National Cancer Institute | 2024 to 2025 | $469,512 | April 1, 2024 | March 31, 2027 | CONKLIN, HEATHER M | reporter.nih.gov |
| Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | NIH | National Institute of General Medical Sciences | 2025 | $462,500 | January 1, 2025 | November 30, 2029 | MA, PEIJUN | reporter.nih.gov |
| PreDM: An adaptive, open-label, pilot intervention trial for diabetes prevention | NIH | National Cancer Institute | 2022 to 2023 | $458,997 | August 1, 2022 | July 31, 2025 | DIXON, STEPHANIE BERRY | reporter.nih.gov |
| Ribonucleotide Reductase in Hepatoblastoma Progression and Drug Resistance | NIH | National Cancer Institute | 2021 to 2022 | $456,505 | January 1, 2021 | December 31, 2023 | ZHU, LIQIN | reporter.nih.gov |
| Cerebrospinal fluid derived circulating tumor DNA as a clinically relevant biomarker in medulloblastoma | NIH | National Cancer Institute | 2021 to 2022 | $456,505 | January 1, 2021 | December 31, 2022 | NORTHCOTT, PAUL | reporter.nih.gov |
| Mitochondrial matrix-localized MCL-1 regulates hematopoietic stem cell self-renewal and regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 | $455,000 | September 22, 2022 | August 31, 2024 | OPFERMAN, JOSEPH T. | reporter.nih.gov |
| Dissecting neuron-microglia-astrocyte interaction in AD pathogenesis | NIH | National Institute on Aging | 2023 | $455,000 | September 15, 2020 | August 31, 2024 | PENG, JUNMIN | reporter.nih.gov |
| Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors | NIH | National Cancer Institute | 2024 to 2025 | $452,634 | January 8, 2024 | December 31, 2026 | PHILLIPS, NICHOLAS S | reporter.nih.gov |
| Establishment, maintenance, and consequences of asymmetric cell division in T cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $448,750 | March 1, 2017 | February 28, 2022 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $443,456 | April 1, 2022 | August 19, 2024 | DOERFLER, PHILLIP A | reporter.nih.gov |
| Pediatric Oncology Career Development Program at St. Jude | NIH | National Cancer Institute | 2024 to 2025 | $415,513 | April 1, 2024 | March 31, 2029 | ROBERTS, CHARLES | reporter.nih.gov |
| Identifying the pathways that drive progression of the MPNs to AML | NIH | National Cancer Institute | 2021 | $415,273 | March 1, 2021 | September 21, 2021 | CRISPINO, JOHN D | reporter.nih.gov |
| Defining the non-myogenic origins of pediatric rhabdomyosarcoma | NIH | National Cancer Institute | 2021 | $410,606 | April 5, 2017 | March 31, 2023 | HATLEY, MARK EDWARD | reporter.nih.gov |
| Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma | NIH | National Cancer Institute | 2021 | $410,606 | June 15, 2017 | May 31, 2023 | DYER, MICHAEL A | reporter.nih.gov |
| Development of small molecules to target KDM4B | NIH | National Cancer Institute | 2021 | $410,606 | July 1, 2018 | June 30, 2022 | YANG, JUN | reporter.nih.gov |
| Targeting Metabolic Liabilities of Leukemia-Initiating Cells (R01CA230631) | NIH | National Cancer Institute | 2023 | $407,999 | February 1, 2019 | January 31, 2025 | XU, JIAN | reporter.nih.gov |
| Novel hematopoietic stem cell specification signals from the neural crest | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $403,875 | August 2, 2017 | May 31, 2024 | CLEMENTS, WILSON KENDRICK | reporter.nih.gov |
| Polarity Signals Coordinate Neuronal Migration and Germinal Zone Exit | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $392,656 | September 1, 2011 | June 30, 2023 | SOLECKI, DAVID JOSEPH | reporter.nih.gov |
| Mechanisms of leukemogenesis in Down syndrome | NIH | National Cancer Institute | 2021 | $383,681 | February 11, 2021 | September 21, 2021 | CRISPINO, JOHN D | reporter.nih.gov |
| Elucidating the structural basis of mitochondrial outer membrane permeabilization in apoptosis | NIH | National Institute of General Medical Sciences | 2021 | $376,950 | September 1, 2020 | June 30, 2022 | MOLDOVEANU, TUDOR | reporter.nih.gov |
| US-UK-China Collab: Understanding the Impact of Poultry Vaccination on H5Nx Avian Influenza Virus Evolution and Ecosystem Dynamics | NSF | Division Of Environmental Biology | 2024 | $376,465 | June 1, 2024 | June 26, 2025 | Richard J Webby | nsf.gov |
| Defining and targeting asparaginase resistance mechanisms in high-risk acute leukemias | NIH | National Cancer Institute | 2024 | $373,507 | September 1, 2015 | May 31, 2025 | GUTIERREZ, ALEJANDRO | reporter.nih.gov |
| Regulation of Mitochondrial Gene Expression and Function by GDF11 Signaling | NIH | National Institute on Aging | 2021 | $367,975 | September 1, 2017 | May 31, 2023 | DEMONTIS, FABIO | reporter.nih.gov |
| Web-based Physical Activity Intervention for Children with ALL | NIH | National Cancer Institute | 2022 | $364,149 | July 1, 2016 | June 30, 2025 | NESS, KIRSTEN KIMBERLIE | reporter.nih.gov |
| Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia | NIH | National Cancer Institute | 2021 to 2024 | $350,888 | February 1, 2021 | January 31, 2025 | NIEDERKORN, MADELINE | reporter.nih.gov |
| Collaborative Research: Engineering host-associated synthetic consortia based on ecological modules. | NSF | Molecular Biosciences | 2025 | $340,796 | January 1, 2025 | August 31, 2027 | Salvador Almagro-Moreno | nsf.gov |
| Consequences of gain-of-function RPA1 mutations on telomere function and hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $338,646 | September 15, 2022 | December 13, 2024 | SHARMA, RICHA | reporter.nih.gov |
| Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $336,722 | July 1, 2021 | March 31, 2026 | KENNEDY, ALYSSA | reporter.nih.gov |
| Enhancing operational efficiency and animal welfare through the use of digital ventilated caging for laboratory mice in an ABSL3 Select Agent biocontainment program | NIH | Office of the Director, National Institutes of Health | 2024 | $327,477 | July 15, 2024 | June 30, 2025 | PISHARATH, HARSHAN | reporter.nih.gov |
| Effects of germline GATA3 variants on ALL somatic genomics and prognosis in multi-ethnic populations | NIH | National Cancer Institute | 2022 | $299,999 | September 15, 2022 | August 31, 2024 | YANG, JUN J. | reporter.nih.gov |
| Dissecting Persistent Cell Populations in Rhabdomyoscaroma | NIH | National Cancer Institute | 2025 | $290,017 | July 15, 2025 | June 30, 2030 | PATEL, ANAND G | reporter.nih.gov |
| Hypofractionated radiation in combination with B7-H3-CAR T cells for pediatric patients with relapsed/refractory sarcomas | NIH | National Cancer Institute | 2025 | $289,937 | August 20, 2025 | July 31, 2030 | EPPERLY, REBECCA ANNE | reporter.nih.gov |
| Functional and Pharmacologic Investigation of the NUP98 Fusion Oncoprotein Interactome | NIH | National Cancer Institute | 2023 to 2024 | $281,918 | August 1, 2023 | July 31, 2025 | MICHMERHUIZEN, NICOLE | reporter.nih.gov |
| Investigating the role of RHOBTB2 in DEE to develop novel therapies | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $277,500 | April 1, 2025 | March 31, 2027 | MEFFORD, HEATHER C. | reporter.nih.gov |
| Methylphenidate to Address Executive Functioning Impairment in Pediatric Patients with Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $277,500 | August 1, 2025 | July 31, 2027 | HEITZER, ANDREW M | reporter.nih.gov |
| CAREER: Convergent molecular mechanisms regulating dormancy in Vibrios | NSF | Infrastructure, Institutes, & Centers | 2025 | $273,619 | January 1, 2025 | April 30, 2027 | Salvador Almagro-Moreno | nsf.gov |
| Role of BCL11B in lineage ambiguous leukemia | NIH | National Cancer Institute | 2023 to 2024 | $272,352 | September 20, 2023 | August 31, 2025 | MONTEFIORI, LINDSEY | reporter.nih.gov |
| Elucidating the role of DCAF7 on hematopoietic stem cell maintenance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $269,098 | September 15, 2023 | July 31, 2028 | MELO-CARDENAS, JOHANNA | reporter.nih.gov |
| Gene regulatory mechanisms governed by the ASXL1/HCF1/OGT complex during neurogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $268,946 | July 1, 2022 | June 30, 2027 | CASTRO, VICTORIA L | reporter.nih.gov |
| Basic and Translational Research Training in Pediatric Classical Hematology | NIH | National Heart, Lung, and Blood Institute | 2025 | $250,251 | January 1, 2025 | December 31, 2029 | MCKINNEY-FREEMAN, SHANNON L | reporter.nih.gov |
| Improving CAR T cell therapy for brain tumors using immune competent models | NIH | National Cancer Institute | 2021 to 2022 | $250,046 | January 1, 2021 | December 31, 2022 | HAYDAR, DALIA | reporter.nih.gov |
| The electrophysiology of biofilm development and drug resistance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $248,999 | July 6, 2023 | August 31, 2027 | MEYER, CHRISTIAN T | reporter.nih.gov |
| Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors | NIH | National Cancer Institute | 2021 to 2022 | $246,776 | January 3, 2021 | June 30, 2022 | WILLIAMS, ANNALYNN | reporter.nih.gov |
| Novel computational approaches for pharmacogenomic discovery | NIH | National Human Genome Research Institute | 2021 | $243,652 | February 1, 2019 | January 31, 2023 | GEELEHER, PAUL | reporter.nih.gov |
| Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $218,266 | April 1, 2022 | March 31, 2025 | BARVE, ADITYA SHIRISH | reporter.nih.gov |
| The Genetic Study of Families with a High Frequency of Hematopoietic Malignancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $213,287 | May 1, 2021 | September 1, 2023 | FLERLAGE, JAMIE ELIZABETH | reporter.nih.gov |
| Investigating the cellular responses to influenza virus infection and the origins of first exposure immune imprinting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $209,964 | September 1, 2021 | August 31, 2024 | METTELMAN, ROBERT C | reporter.nih.gov |
| TONSILS: AN UNRECOGNIZED ROLE IN INFLUENZA VIRUS EVOLUTION | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $200,000 | August 4, 2022 | July 31, 2025 | OKDA, FATEN ABDELAAL | reporter.nih.gov |
| MECHANISMS REGULATING AVIAN INFLUENZA VIRUS INFECTIONS IN HUMANS | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $190,882 | February 16, 2017 | January 31, 2022 | WEBBY, RICHARD JOHN | reporter.nih.gov |
| Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $186,500 | July 1, 2023 | June 30, 2025 | RYBAK, JEFFREY M. | reporter.nih.gov |
| Astrovirus CNS Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $182,000 | November 1, 2021 | October 31, 2023 | SCHULTZ-CHERRY, STACEY L | reporter.nih.gov |
| Legacy of Obesity on Influenza and Coronavirus | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $182,000 | November 1, 2021 | October 31, 2023 | SCHULTZ-CHERRY, STACEY L | reporter.nih.gov |
| A genetic switch to study the causal roles of T cell repertoire diversity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $182,000 | January 5, 2022 | December 31, 2023 | FENG, YONGQIANG | reporter.nih.gov |
| Elucidating function of disease-related SAMD9L mutations in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $180,000 | June 1, 2023 | May 31, 2026 | SAHOO, SUSHREE S | reporter.nih.gov |
| Hematopoietic stem cell defects in Diamond-Blackfan Anemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $179,880 | April 1, 2024 | March 31, 2026 | BHOOPALAN, SENTHIL VELAN | reporter.nih.gov |
| A novel circuit underlying amotivation in a mouse model of 22q11DS | NIH | National Institute of Mental Health | 2023 to 2024 | $176,748 | December 12, 2022 | November 30, 2024 | PATTON, MARY H. | reporter.nih.gov |
| Experimental and preclinical modeling of NUP98-rearranged acute leukemia | NIH | National Cancer Institute | 2023 | $161,500 | September 1, 2023 | August 31, 2025 | MULLIGHAN, CHARLES G. | reporter.nih.gov |
| Genetically faithful modeling of NUP98 rearrangement and co-alterations in acute myeloid leukemia | NIH | National Cancer Institute | 2021 to 2023 | $159,540 | April 1, 2021 | July 31, 2023 | MICHMERHUIZEN, NICOLE | reporter.nih.gov |
| Impact of obesity on antiviral NK cell function and immune crosstalk with respiratory epithelial cells during influenza virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $152,324 | September 1, 2024 | August 31, 2026 | BRIGLEB, PAMELA | reporter.nih.gov |
| Impact of bidirectional signaling between megakaryocytes and osteosarcoma cells on metastasis | NIH | National Cancer Institute | 2024 to 2025 | $152,324 | May 15, 2024 | May 14, 2027 | TRAVIS, OLIVIA KRISTELL | reporter.nih.gov |
| What is the mechanism by which a gene essential for Rhabdoid tumor viability regulates Chromatin function? | NIH | National Cancer Institute | 2024 to 2025 | $152,324 | July 15, 2024 | July 14, 2027 | COCKFIELD, JORDAN A. | reporter.nih.gov |
| Bacterial anti-inflammatory lipid mediators | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $147,454 | February 17, 2022 | June 1, 2023 | RADKA, CHRISTOPHER DAVID | reporter.nih.gov |
| THE FUNCTION OF CASPASE-8 IN CANCER, ANTI-CANCER IMMUNITY, AND CAR-T CELL FUNCTION | NIH | National Cancer Institute | 2024 to 2025 | $145,676 | July 1, 2024 | April 30, 2026 | SHAW, JEREMY JOSEPH PORTER | reporter.nih.gov |
| GPRASP family as novel regulators in hematopoietic stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $90,000 | July 1, 2020 | June 30, 2023 | MORALES-HERNANDEZ, ANTONIO | reporter.nih.gov |
| The Molecular and Biochemical Function of SAMD9 and SAMD9L in Pediatric MDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $89,501 | August 1, 2020 | September 30, 2022 | THOMAS, MELVIN EDWARD | reporter.nih.gov |
| Role of WT1 in mixed phenotype acute leukemia | NIH | National Cancer Institute | 2021 to 2022 | $86,828 | July 1, 2020 | September 30, 2022 | MONTEFIORI, LINDSEY | reporter.nih.gov |
| Mucin inhibits pneumococcal stationary phase autolysis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $86,267 | August 1, 2024 | September 30, 2025 | JOHNSON, CYDNEY N | reporter.nih.gov |
| Strategies and Consequences of Polymicrobial Nasal Colonization | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $75,520 | November 1, 2025 | October 31, 2028 | WILDE, SHYRA | reporter.nih.gov |
| Elucidating the role of an essential transcription factor in SWI/SNF -mutant rhabdoid tumors | NIH | National Cancer Institute | 2025 | $75,520 | August 1, 2025 | July 31, 2028 | BALINTH, SEAMUS | reporter.nih.gov |
| Defining mechanistic drivers of impaired B cell response to influenza A virus vaccine under conditions of obesity | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $75,052 | July 1, 2025 | June 30, 2027 | RIPPERGER, TYLER | reporter.nih.gov |
| Decoding Influenza-Induced Damage: What's all the Hyp(oxia) about? | NIH | National Heart, Lung, and Blood Institute | 2025 | $75,052 | December 1, 2025 | November 30, 2028 | HUCKESTEIN, BRYDIE RYAN | reporter.nih.gov |
| Determining the developmental origins of retinoblastoma | NIH | National Cancer Institute | 2021 | $72,958 | April 1, 2019 | March 31, 2022 | NORRIE, JACQUELINE | reporter.nih.gov |
| Gprasp2 expression identifies a deeply quiescent hematopoietic stem cells subset with superior stemness and self-renewal | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $69,500 | December 1, 2023 | November 30, 2024 | VAN HUIZEN, ALANNA V | reporter.nih.gov |
| Novel Regulators of GPCR Signaling in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $68,562 | September 16, 2019 | September 15, 2022 | NEVITT, CHRISTOPHER DAVID | reporter.nih.gov |
| Functional evaluation of clonal hematopoiesis of indeterminate potential (CHIP) | NIH | National Heart, Lung, and Blood Institute | 2021 | $64,704 | July 15, 2020 | June 30, 2022 | BARAJAS, JUAN M. | reporter.nih.gov |
| Probing the prevalence and molecular mechanisms of phase separation by fusion oncoproteins | NIH | National Institute of General Medical Sciences | 2021 | $47,968 | September 13, 2021 | May 12, 2022 | GORMAN, SCOTT DANIEL | reporter.nih.gov |
| Investigating mechanisms underscoring dichotomous T cell responses between medulloblastoma subgroups | NIH | National Cancer Institute | 2021 | $47,563 | January 1, 2021 | August 27, 2021 | BOI, SHANNON | reporter.nih.gov |
| Defining Clinical Research Priorities and Strengthening Diversity and Patient-Stakeholder Engagement in Histiocytic Disorders | NIH | National Center for Advancing Translational Sciences | 2024 | $30,000 | January 1, 2024 | December 31, 2024 | RODRIGUEZ-GALINDO, CARLOS | reporter.nih.gov |
| Workshop on the Pathology of Mouse Models for Human Disease | NIH | Office of the Director, National Institutes of Health | 2025 | $22,000 | September 1, 2025 | August 31, 2029 | JANKE, LAURA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 161 | $130,963,372 | 1 | $160,085 |
| 2024 | 152 | $112,724,087 | 3 | $1,049,341 |
| 2023 | 139 | $115,747,062 | 1 | $340,796 |
| 2022 | 137 | $102,958,597 | 0 | $0 |
| 2021 | 136 | $108,744,446 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 4 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) | PA-24-181 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 58 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 58 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 58 awards here |
Topics of its NIH awards
- Genetics
- Rare Diseases
- Cancer
- Pediatric
- Pediatric Cancer
- Neurosciences
- Biotechnology
- Human Genome
- Hematology
- Clinical Research
- Orphan Drug
- Infectious Diseases
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.